A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial
John L. Sapp, Anthony Tang, Ratika Parkash, William G. Stevenson, Jeff S. Healey, George A. Wells
Topics & Concepts
MedicineAmiodaroneCardiologyInternal medicineVentricular tachycardiaMyocardial infarctionSotalolCatheter ablationCardiomyopathyIschemic cardiomyopathyClinical trialAnesthesiaAblationHeart failureAtrial fibrillationEjection fractionCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studiesAtrial Fibrillation Management and Outcomes